The role of cerebral pressure autoregulation (CPA) in brain injury and disorders has gained increased interest. The CPA is often disturbed as a consequence of acute brain injury, which contributes to further brain damage and worse outcome. Specifically, in severe traumatic brain injury, CPA disturbances predict worse clinical outcome and targeting an autoregulatory-oriented optimal cerebral perfusion pressure threshold may improve brain energy metabolism and clinical outcome. In aneurysmal subarachnoid hemorrhage, cerebral vasospasm in combination with distal autoregulatory disturbances precipitate delayed cerebral ischemia. The role of optimal cerebral perfusion pressure targets is less clear in aneurysmal subarachnoid hemorrhage, but high cerebral perfusion pressure targets are generally favorable in the vasospasm phase. In acute ischemia, autoregulatory disturbances may occur and autoregulatory-oriented blood pressure (optimal mean arterial pressure) management reduces the risk of hemorrhagic transformation, brain edema, and unfavorable outcome. In chronic occlusive disease such as moyamoya, the gradual reduction of the cerebral circulation leads to compensatory distal vasodilation and the residual CPA capacity predicts the risk for cerebral ischemia. In spontaneous intracerebral hemorrhage, the role of autoregulatory disturbances is less clear, but CPA disturbances correlate with worse clinical outcome. Also, in community-acquired bacterial meningitis, CPA dysfunction is frequent and correlates with worse clinical outcome, but autoregulatory management is yet to be evaluated. In this review, we discuss the role of CPA in different types of brain injury and disease, the strengths and limitations of the monitoring methods, the potentials of autoregulatory management, and future directions in the field.
Current guidelines in traumatic brain injury (TBI) recommend a cerebral perfusion pressure (CPP) within the fixed interval 60-70 mm Hg. However, the autoregulatory, optimal CPP-target (CPPopt) might yield better cerebral blood flow (CBF)-regulation. In this study, we investigated fixed vs. autoregulatory CPP-targets in relation to cerebral energy metabolism and clinical outcome after TBI. Ninety-eight non-craniectomized patients with severe TBI treated in the neurointensive care unit, Uppsala University Hospital, Sweden, 2008-2018, were included. Data from cerebral microdialysis (MD), intracranial pressure (ICP), pressure autoregulation, CPP and CPPopt55-15 (a variant of CPPopt based on filtered slow waves from 15 – 55 sec range) were analyzed the first ten days. The good monitoring time (GMT %) below/within/above the fixed and autoregulatory CPP-targets were calculated. CPPopt55-15 was above 70 mm Hg 74% of the time the first 10 days. Higher GMT (%) ∆CPPopt55-15 ±10 mm Hg correlated with lower lactate-/pyruvate-ratio (LPR) day 1 and lower cerebral glycerol day 6 to 10, and predicted favorable clinical outcome. Higher GMT (%) CPP within 60-70 mm Hg correlated with lower cerebral glucose day 2-10 and higher LPR day 6 to 10, but predicted favorable clinical outcome. Higher GMT (%) CPP > 70 mm Hg had the opposite associations, i.e. with higher cerebral glucose and lower LPR, but unfavorable clinical outcome. Autoregulatory CPP-targets may be beneficial, since patients with CPP-values close to the optimal CPP had both better cerebral energy metabolism and better clinical outcome, but this needs to be evaluated in randomized trials.
Decompressive craniectomy (DC) relieves intracranial hypertension following severe traumatic brain injury (TBI), but it has been associated with poor clinical outcome in two recent randomized controlled trials. In this study, we investigated the incidence and explanatory variables for DC- and cranioplasty (CP)-related complications after TBI. In this retrospective study, we identified 61 TBI patients who were treated with DC in the neurointensive care (NIC) unit, Uppsala University Hospital, Sweden, between 2008 and 2018. Demography, admission status, radiology, and clinical outcome were analysed. Eleven (18%) patients were re-operated due to post-operative hemorrhage after DC. Six (10%) developed post-operative infection during the NIC. Twenty-eight (46%) developed subdural hygromas and 10 (16%) received permanent cerebrospinal fluid shunt. Sixteen (26%) patients died before CP. Median time to CP was 7 months (range 2-19) and 32 (71%) were operated with autologous bone and 13 (29%) with synthetic material primarily. In nine (29%) patients with autologous bone, the CP had to be replaced due to bone resorption/infection, whereas this did not occur after synthetic material (p-value = 0.04). However, all four post-operative hemorrhages following CP occurred when synthetic material was used (p-value = 0.005). DC- and CP-surgery have a high risk for complications leading to additional neurosurgery in about one third of the cases, respectively. Synthetic CP materials may decrease the risk of re-operation, but special care to hemostasis is required due to increased risk of post-operative hemorrhage. Future trials need to address these topics to further improve the outcome for these patients.
Background Arterial hyperglycemia is associated with poor outcome in traumatic brain injury (TBI), but the pathophysiology is not completely understood. Previous preclinical and clinical studies have indicated that arterial glucose worsens pressure autoregulation. The aim of this study was to evaluate the relationship of arterial glucose to both pressure reactivity and cerebral energy metabolism. Method This retrospective study was based on 120 patients with severe TBI treated at the Uppsala University hospital, Sweden, 2008–2018. Data from cerebral microdialysis (glucose, pyruvate, and lactate), arterial glucose, and pressure reactivity index (PRx55-15) were analyzed the first 3 days post-injury. Results High arterial glucose was associated with poor outcome/Glasgow Outcome Scale-Extended at 6-month follow-up (r = − 0.201, p value = 0.004) and showed a positive correlation with both PRx55-15 (r = 0.308, p = 0.001) and cerebral lactate/pyruvate ratio (LPR) days 1–3 (r = 0. 244, p = 0.014). Cerebral lactate-to-pyruvate ratio and PRx55-15 had a positive association day 2 (r = 0.219, p = 0.048). Multivariate linear regression analysis showed that high arterial glucose predicted poor pressure autoregulation on days 1 and 2. Conclusions High arterial glucose was associated with poor outcome, poor pressure autoregulation, and cerebral energy metabolic disturbances. The latter two suggest a pathophysiological mechanism for the negative effect of arterial hyperglycemia, although further studies are needed to elucidate if the correlations are causal or confounded by other factors.